Details

Chaired by Andrew Jack, Pharmaceuticals Correspondent of the Financial Times, the FT Global Pharmaceutical and Biotechnology Conference, now in its 27th successful year, brings together leading industry executives, government decision makers, investors, analysts and other specialist providers to discuss the latest industry developments, and provide insights that will help you identify, anticipate and meet tomorrow's challenges head on .

Speakers Include:

Joseph Jimenez, Chief Executive Officer, Novartis

David Brennan, Chief Executive Officer, AstraZeneca

Eddie Gray, President, Pharmaceuticals Europe, GlaxoSmithKline

Dr Erich Hunziker, Chief Financial and IT Officer, Roche

Dr Roch Doliveux, Chief Executive Officer, UCB

Jérôme Contamine, EVP, Chief Financial Officer, Sanofi-Aventis

Dr Jan Lundberg, EVP, Science and Technology and President, Lilly Research Laboratories

Jeffrey Berkowitz, SVP, Global Market Access, Merck & Co

Timothy C Tyson, Chairman and CEO, Aptuit, Inc

Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence (NICE)

Ken Jones, Chief Operating Officer, Astellas Pharma Europe Ltd

Carolyn M Clancy MD, Director, Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services

Gerry Migliaccio, SVP, Network Performance, Pfizer Global Manufacturing, Pfizer Inc

Rolf Hoffmann, Senior Vice President, Amgen International

For further information on the programme, please visit

www.ftconferences.com/pharmabio

 

Prices

Pharmiweb readers get a 20% discount, register using discount code FTPW20

Contact

Amelie Argenti
amelie.argenti@FT.com